Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of levetiracetam and sodium valproate in juvenile myoclonic epilepsy
IRCT2013112715567N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of levetiracetam and valproic acid in juvenile myoclonic epilepsy (JME) and Genetic generalized epilepsy (GGE) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Seizure attack frequency. Started Apr 2012; status: completed.
02
Drugs
levetiracetamvalproic acid
03
Conditions
juvenile myoclonic epilepsy (JME)Genetic generalized epilepsy (GGE)
Beyond the preview
Go deeper on IRCT2013112715567N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013112715567N1.